Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03631706
Brief Title: M7824 Versus Pembrolizumab as a First-line (1L) Treatment in Participants With Programmed Death-ligand 1 (PD-L1) Expressing Advanced Non-small Cell Lung Cancer (NSCLC)

First Submitted : August 9, 2018
First Submitted that Met QC Criteria : August 13, 2018
First Posted : August 15, 2018

Last Update Submitted that Met QC Criteria : December 5, 2019
Last Update Posted : December 6, 2019